BRAF and melanoma: In order to assess in greater detail this aspect we conducted the present study in a panel of V600 BRAF-mutated human melanoma cell lines and utilizing a combination of approaches involving the use of conditioned medium from BRAFi exposed cells and of neutralizing antibodies against NRG1.